SCHEMBL2498576

SCHEMBL2498576

CCOC(=O)OCC1COC(=O)N1c1cc(F)c(N2CCN(C(=O)OC(C)(C)C)CC2)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.39
ALOX15 P16050 3/20 0.39
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
USP2 O75604 1/20 0.39
TP53 P04637 1/20 0.39
ALOX12 P18054 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 7/20 0.38
MAPT P10636 7/20 0.38
GAA P10253 2/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 2/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
GPR119 Q8TDV5 2/20 0.37
HTT P42858 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
DPP4 P27487 1/20 0.36
MEN1 O00255 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2507043 0.87 GPR119 (0.41) LMNAALDH1A1MAPTKDM4EGPR119
SCHEMBL2499942 0.87 GPR119 (0.39) GPR119
SCHEMBL2480377 0.86 GPR119 (0.40) LMNAALDH1A1MAPTKDM4EGPR119
SCHEMBL2480116 0.86 ALDH1A1 (0.37) HPGDALOX15LMNASMN1; SMN2USP2
SCHEMBL2452755 0.85 MAOA (0.40) LMNASMN1; SMN2ALDH1A1MAPTGPR119
SCHEMBL2498574 0.82 MAOB (0.44) HPGDALOX15LMNASMN1; SMN2USP2
SCHEMBL2503392 0.82 GPR119 (0.37) LMNASMN1; SMN2ALDH1A1MAPTKDM4E
SCHEMBL2502268 0.82 GPR119 (0.38) LMNAALDH1A1MAPTGPR119
SCHEMBL2486343 0.80 GPR119 (0.37) SMN1; SMN2GPR119HTTDPP4MEN1
SCHEMBL2501461 0.80 MAOA (0.38) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8841306-B2 Antimicrobials PANACEA BIOTEC LTD. (IN) 2014-09-23 US disclosed
US-20110245258-A1 NOVEL ANTIMICROBIALS PANACEA BIOTEC LTD. (IN) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245258-A1 NOVEL ANTIMICROBIALS ECI1, XDH, CYP3A4 HPGD 348/4885ALOX15 958/4885LMNA 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.